安捷伦科技股票:静默上涨,棘手问题——实验室巨头在C轮融资后是否仍值得买入?
Agilent Technologies Stock: Quiet Rally, Hard Questions – Is The Lab Giant Still A Buy After Its C - AD HOC NEWS
生物技术与制药领域的最新动态
Agilent Technologies Stock: Quiet Rally, Hard Questions – Is The Lab Giant Still A Buy After Its C - AD HOC NEWS
More Than Beer and Cheese: Why Wisconsin Has Always Been Good Ground for Science
Lonza Group Ag (OTCMKTS:LZAGY) Short Interest Update - MarketBeat
Assessing Thermo Fisher Scientific (TMO) Valuation After Recent Share Price Weakness - simplywall.st
Illinois Municipal Retirement Fund Trims Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Rhumbline Advisers Buys 7,636 Shares of Waters Corporation $WAT - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by Coronation Fund Managers Ltd. - MarketBeat
Illumina Conservation Deal Highlights New Genomics Demand And Valuation Debate - simplywall.st
Transforming Effective Patient Recruitment Within The Changing Health Care Landscape - Clinical Leader
Assessing 10x Genomics (TXG) Valuation After Recent Share Price Momentum - simplywall.st
10x Genomics Earnings Call: Consumables Shine, CapEx Bites - TipRanks
Lonza’s Stock In Recovery Mode: Is This Swiss CDMO Finally Back On Track? - AD HOC NEWS
Lonza’s Stock In Recovery Mode: Is This Swiss CDMO Finally Back On Track? - AD HOC NEWS
The Bull Case For Agilent Technologies (A) Could Change Following New PD-L1 Test Approval And Dividend News - simplywall.st
Moderna vs FDA; Paul Hudson out at Sanofi; Why clinical trials are so costly; and more
Agilent Technologies, Inc. $A Shares Sold by ING Groep NV - MarketBeat
Thermo Fisher Scientific (TMO) Announces $3.8 Billion Senior Not - GuruFocus
Assetmark Inc. Boosts Position in Agilent Technologies, Inc. $A - MarketBeat
Illumina (NASDAQ:ILMN) Upgraded by Wall Street Zen to Strong-Buy Rating - MarketBeat
Risk Factors Weigh on 10X Genomics: Uncertain Guidance, Stock Volatility, and Capital-Raising Challenges - TipRanks